Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...
An experimental oral drug called muvalaplin shows promise in reducing the cholesterol linked to heart disease in a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback